Modis Therapeutics competitors and similar companiesClear all

Amicus Therapeutics's competitors and similar companies include Bluebird Bio.
Amicus Therapeutics
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Bluebird Bio
Bluebird Bio
Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.
Founding Date
Founding Date
2002
Founding Date
1992
Type
Type
Public
Type
Public
Tags
Locations
Locations
Philadelphia, US HQ
Northbridge, AU
Pointe Claire, CA
Paris, FR
München, DE
Dublin, IE
Milano, IT
see more
Locations
Cambridge, US HQ
Paris, FR
München, DE
Athens, GR
Milano, IT
Utrecht, NL
Zug, CH
see more
Employees
Employees
58415% increase
Employees
1,2134% increase
Valuation ($)
Valuation ($)
2.9 b
Valuation ($)
443.8 m
Twitter followers
Twitter followers
2 k
Twitter followers
10.5 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
19
Number of tweets (last 30 days)
17
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
15.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
84.21%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
371560
Alexa Website Rank
438682
Employee Rating
Employee Rating
2.9
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$305.5m (FY, 2021)
Revenue (est.)
$3.7m (FY, 2021)
Net income
Net income
($250.5m) (FY, 2021)
Net income
($819.4m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 88m
Total funding raised
$ 409m
For sources of this data, please see the company profile

View company profiles

Bluebird Bio
HQ
Cambridge, US
Employees
1,213↑ 4% increase

Bluebird Bio is a developer of gene therapies for severe genetic diseases and cancer.

View company